Skip to content
PeptideWiki.bio

Sexual and reproductive health

Leuprolide

Also called Lupron, Leuprorelin

InjectableEvidence AEvery day
Half-life
3hours
Typical vial
1 / 5mg
Research amounts
1–7.5mg

per administration

Common schedule
Every day
Tested in people

A human trial worked out how much to take and how often, so a dosing schedule is shown.

Licensed as a medicine in the US and EU.

Quick start

Leuprolide at a glance — the figures, plus how it's commonly run. Reference only, not medical advice.

Typical dose
1–7.5 mg per administration
How often
Every day
Where
Subcutaneous — abdomen, thigh, or upper arm Sites and rotation
Time to steady level
~15 hours — about five half-lives
Storage
Dry vial kept cold and dark; a mixed vial in the fridge at 2–8 °C. Details

A research and community reference, not medical advice. Figures are descriptive, vary between sources, and are not a recommendation for use.

Work out your draw

These numbers are a starting point — change any of them.

Vial label

Copy this into your label printer.

Published research contexts for Leuprolide describe 17.5 mg per administration. Descriptive only, not a recommendation.

About 3 hours for the immediate-release peptide; the licensed depot releases over one to six months, with different kinetics.

A gonadotropin-releasing hormone agonist, licensed as a medicine as both a 1 mg daily subcutaneous form and a long-acting depot; because the depot dominates use and no dose-ranging escalation applies, no schedule table is shown.

Modelled level — every day

1× is the peak after a single dose.

Steady-state peak
1.00× single dose

Read off the modelled curve, not an even-interval formula

Time to steady state
15hours

About five half-lives

Administrations
7/ week

Where these numbers come from

  • Leuprolide (Lupron) product literatureA licensed GnRH agonist given as 1 mg daily subcutaneously or as a monthly-to-six-monthly depot.

Next steps

Others in sexual and reproductive health